{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:12:16Z","timestamp":1788361936164,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10528-025-11038-x","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T12:44:38Z","timestamp":1738154678000},"page":"386-400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Epigenetic Control of Hyperuricemia and Gout by Gene Writer DNMT1 and RNA Editor ADAR1: Mechanism of Gout and Amyloid Dissolution in Down Syndrome"],"prefix":"10.1007","volume":"64","author":[{"given":"Suresh C.","family":"Tyagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Smolenkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahavir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"11038_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/ijpvm.IJPVM_322_16","volume":"8","author":"A Abareshi","year":"2017","unstructured":"Abareshi A, Norouzi F, Asgharzadeh F, Beheshti F, Hosseini M, Farzadnia M et al (2017) Effect of angiotensin-converting enzyme inhibitor on cardiac fibrosis and oxidative stress status in lipopolysaccharide-induced inflammation model in rats. Int J Prev Med 8:69","journal-title":"Int J Prev Med"},{"issue":"4","key":"11038_CR2","doi-asserted-by":"publisher","first-page":"H542","DOI":"10.1152\/ajpheart.00544.2022","volume":"324","author":"ML Bates","year":"2023","unstructured":"Bates ML, Vasileva A, Flores LDM, Pryakhina Y, Buckman M, Tomasson MH et al (2023) Sex differences in cardiovascular disease and dysregulation in Down syndrome. Am J Physiol Heart Circ Physiol 324(4):H542\u2013H552","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"11038_CR3","doi-asserted-by":"publisher","first-page":"1203483","DOI":"10.3389\/fonc.2023.1203483","volume":"13","author":"Y Bejaoui","year":"2023","unstructured":"Bejaoui Y, Alresheq S, Durand S, Vilaire-Meunier M, Maillebouis L, Zen AAH et al (2023) DNA methylation profiling in Trisomy 21 females with and without breast cancer. Front Oncol 13:1203483","journal-title":"Front Oncol"},{"issue":"3","key":"11038_CR4","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/jcph.1970","volume":"62","author":"Y Chino","year":"2022","unstructured":"Chino Y, Kuwabara M, Hisatome I (2022) Factors influencing change in serum uric acid after administration of the sodium-glucose cotransporter 2 inhibitor luseogliflozin in patients with type 2 diabetes mellitus. J Clin Pharmacol 62(3):366\u2013375","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"11038_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.33549\/physiolres.934791","volume":"71","author":"BT Cilhoroz","year":"2022","unstructured":"Cilhoroz BT, Receno CN, Heffernan KS, Deruisseau LR (2022) Cardiovascular physiology and pathophysiology in Down syndrome. Physiol Res 71(1):1\u201316","journal-title":"Physiol Res"},{"key":"11038_CR6","doi-asserted-by":"publisher","first-page":"1110163","DOI":"10.3389\/fnins.2022.1110163","volume":"16","author":"P Conan","year":"2022","unstructured":"Conan P, L\u00e9on A, Caroff N, Rollet C, Cha\u00efr L, Martin J et al (2022) New insights into the regulation of cystathionine beta synthase (CBS), an enzyme involved in intellectual deficiency in Down syndrome. Front Neurosci 16:1110163","journal-title":"Front Neurosci"},{"issue":"1","key":"11038_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.mrrev.2009.06.001","volume":"682","author":"F Copped\u00e8","year":"2009","unstructured":"Copped\u00e8 F (2009) The complex relationship between folate\/homocysteine metabolism and risk of Down syndrome. Mutat Res 682(1):54\u201370","journal-title":"Mutat Res"},{"key":"11038_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1755-8794-3-42","volume":"3","author":"F Copped\u00e8","year":"2010","unstructured":"Copped\u00e8 F, Grossi E, Migheli F, Migliore L (2010) Polymorphisms in folate-metabolizing genes, chromosome damage, and risk of Down syndrome in Italian women: identification of key factors using artificial neural networks. BMC Med Genom 3:42","journal-title":"BMC Med Genom"},{"key":"11038_CR9","first-page":"1","volume":"787","author":"F Copped\u00e8","year":"2016","unstructured":"Copped\u00e8 F, Denaro M, Tannorella P, Migliore L (2016) Increased MTHFR promoter methylation in mothers of Down syndrome individuals. Mutat Res 787:1\u20136","journal-title":"Mutat Res"},{"issue":"17","key":"11038_CR10","doi-asserted-by":"publisher","first-page":"e14205","DOI":"10.14814\/phy2.14205","volume":"7","author":"LR DeRuisseau","year":"2019","unstructured":"DeRuisseau LR, Receno CN, Heffernan KS, Cunningham CM (2019) Heart rate and blood pressure in male Ts65Dn mice: a model to investigate cardiovascular responses in Down syndrome. Physiol Rep 7(17):e14205","journal-title":"Physiol Rep"},{"issue":"7644","key":"11038_CR11","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.1136\/bmj.39465.544028.AE","volume":"336","author":"JM Ellis","year":"2008","unstructured":"Ellis JM, Tan HK, Gilbert RE, Muller DP, Henley W, Moy R et al (2008) Supplementation with antioxidants and folinic acid for children with Down\u2019s syndrome: randomised controlled trial. BMJ 336(7644):7594\u20137597","journal-title":"BMJ"},{"issue":"12","key":"11038_CR12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1152\/physiolgenomics.00041.2019","volume":"51","author":"AK George","year":"2019","unstructured":"George AK, Homme RP, Majumder A, Tyagi SC, Singh M (2019) Effect of MMP-9 gene knockout on retinal vascular form and function. Physiol Genom 51(12):613\u2013622","journal-title":"Physiol Genom"},{"issue":"3","key":"11038_CR13","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1002\/jcp.29163","volume":"235","author":"AK George","year":"2020","unstructured":"George AK, Singh M, Pushpakumar S, Homme RP, Hardin SJ, Tyagi SC (2020) Dysbiotic 1-carbon metabolism in cardiac muscle remodeling. J Cell Physiol 235(3):2590\u20132598","journal-title":"J Cell Physiol"},{"issue":"6","key":"11038_CR14","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1590\/S0102-311X2002000600035","volume":"18","author":"LB Grillo","year":"2002","unstructured":"Grillo LB, Ac\u00e1cio GL, Barini R, Pinto W Jr, Bertuzzo CS (2002) Mutations in the methylene-tetrahydrofolate reductase gene and Down syndrome. Cad Saude Publica 18(6):1795\u20131797","journal-title":"Cad Saude Publica"},{"issue":"4","key":"11038_CR15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.14336\/AD.2016.0111","volume":"7","author":"MS Gurses","year":"2016","unstructured":"Gurses MS, Ural MN, Gulec MA, Akyol O, Akyol S (2016) Pathophysiological function of ADAMTS Enzymes on molecular mechanism of Alzheimer\u2019s disease. Aging Dis 7(4):479\u2013490","journal-title":"Aging Dis"},{"issue":"3","key":"11038_CR16","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1086\/303055","volume":"67","author":"CA Hobbs","year":"2000","unstructured":"Hobbs CA, Sherman SL, Yi P, Hopkins SE, Torfs CP, Hine RJ et al (2000) Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome. Am J Hum Genet 67(3):623\u2013630","journal-title":"Am J Hum Genet"},{"issue":"1","key":"11038_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13024-023-00640-5","volume":"18","author":"Y Inoue","year":"2023","unstructured":"Inoue Y, Shue F, Bu G, Kanekiyo T (2023) Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer\u2019s disease. Mol Neurodegener 18(1):46","journal-title":"Mol Neurodegener"},{"issue":"4","key":"11038_CR18","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/ajcn\/70.4.495","volume":"70","author":"SJ James","year":"1999","unstructured":"James SJ, Pogribna M, Pogribny IP, Melnyk S, Hine RJ, Gibson JB et al (1999) Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 70(4):495\u2013501","journal-title":"Am J Clin Nutr"},{"key":"11038_CR19","doi-asserted-by":"publisher","first-page":"20831","DOI":"10.1038\/srep20831","volume":"6","author":"J Jiang","year":"2016","unstructured":"Jiang J, Chan A, Ali S, Saha A, Haushalter KJ, Lam WL et al (2016) Hydrogen Sulfide-mechanisms of toxicity and development of an antidote. Sci Rep 6:20831","journal-title":"Sci Rep"},{"issue":"6","key":"11038_CR20","doi-asserted-by":"publisher","first-page":"e1003515","DOI":"10.1371\/journal.pgen.1003515","volume":"9","author":"S Jin","year":"2013","unstructured":"Jin S, Lee YK, Lim YC, Zheng Z, Lin XM, Ng DP et al (2013) Global DNA hypermethylation in Down syndrome placenta. PLoS Genet 9(6):e1003515","journal-title":"PLoS Genet"},{"issue":"1","key":"11038_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41392-020-00454-7","volume":"5","author":"Y Jin","year":"2020","unstructured":"Jin Y, Ji W, Yang H, Chen S, Zhang W, Duan G (2020) Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches. Signal Transduct Target Ther 5(1):293","journal-title":"Signal Transduct Target Ther"},{"key":"11038_CR22","doi-asserted-by":"publisher","first-page":"109289","DOI":"10.1016\/j.mehy.2019.109289","volume":"131","author":"PP Kamoun","year":"2019","unstructured":"Kamoun PP (2019) Mental retardation in Down syndrome: two ways to treat. Med Hypotheses 131:109289","journal-title":"Med Hypotheses"},{"key":"11038_CR23","first-page":"15","volume":"15","author":"HO Lee","year":"2018","unstructured":"Lee HO, Wang L, Kuo YM, Andrews AJ, Gupta S, Kruger WD (2018) S-adenosylhomocysteine hydrolase over-expression does not alter S-adenosylmethionine or S-adenosylhomocysteine levels in CBS deficient mice. Mol Genet Metab Rep 15:15\u201321","journal-title":"Mol Genet Metab Rep"},{"issue":"1","key":"11038_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12933-019-0816-2","volume":"18","author":"C Li","year":"2019","unstructured":"Li C, Zhang J, Xue M, Li X, Han F, Liu X et al (2019) SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. Cardiovasc Diabetol 18(1):15","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"11038_CR25","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1021\/bi901994d","volume":"49","author":"MC Liao","year":"2010","unstructured":"Liao MC, Van Nostrand WE (2010) Degradation of soluble and fibrillar amyloid beta-protein by matrix metalloproteinase (MT1-MMP) in vitro. Biochemistry 49(6):1127\u20131136","journal-title":"Biochemistry"},{"issue":"6","key":"11038_CR26","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S1474-4422(10)70112-5","volume":"9","author":"IT Lott","year":"2010","unstructured":"Lott IT, Dierssen M (2010) Cognitive deficits and associated neurological complications in individuals with Down\u2019s syndrome. Lancet Neurol 9(6):623\u2013633","journal-title":"Lancet Neurol"},{"issue":"10","key":"11038_CR27","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/bdra.20312","volume":"76","author":"WM Meijer","year":"2006","unstructured":"Meijer WM, Werler MM, Louik C, Hernandez-Diaz S, de Jong-van den Berg LT, Mitchell AA (2006) Can folic acid protect against congenital heart defects in Down syndrome? Birth Defects Res A Clin Mol Teratol 76(10):714\u2013717","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"2","key":"11038_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2174\/157016108783955301","volume":"6","author":"KS Moshal","year":"2008","unstructured":"Moshal KS, Metreveli N, Frank I, Tyagi SC (2008) Mitochondrial MMP activation, dysfunction and arrhythmogenesis in hyperhomocysteinemia. Curr Vasc Pharmacol 6(2):84\u201392","journal-title":"Curr Vasc Pharmacol"},{"issue":"3","key":"11038_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.12779\/dnd.2023.22.3.87","volume":"22","author":"\u00d6B Munis","year":"2023","unstructured":"Munis \u00d6B (2023) Association of type 2 diabetes mellitus with perivascular spaces and cerebral amyloid angiopathy in Alzheimer\u2019s disease: insights from MRI imaging. Dement Neurocogn Disord 22(3):87\u201399","journal-title":"Dement Neurocogn Disord"},{"issue":"1","key":"11038_CR30","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/s41467-021-21064-z","volume":"12","author":"IS Muskens","year":"2021","unstructured":"Muskens IS, Li S, Jackson T, Elliot N, Hansen HM, Myint SS et al (2021) The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis. Nat Commun 12(1):821","journal-title":"Nat Commun"},{"issue":"8","key":"11038_CR31","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3390\/genes12081115","volume":"12","author":"OY Naumova","year":"2021","unstructured":"Naumova OY, Lipschutz R, Rychkov SY, Zhukova OV, Grigorenko EL (2021) DNA methylation alterations in blood cells of toddlers with Down syndrome. Genes (Basel) 12(8):1115","journal-title":"Genes (Basel)"},{"issue":"1","key":"11038_CR32","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1038\/s41598-022-05825-4","volume":"12","author":"S Onnivello","year":"2022","unstructured":"Onnivello S, Pulina F, Locatelli C, Marcolin C, Ramacieri G, Antonaros F et al (2022) Cognitive profiles in children and adolescents with Down syndrome. Sci Rep 12(1):1936","journal-title":"Sci Rep"},{"key":"11038_CR33","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.neuroscience.2014.09.078","volume":"284","author":"\u0130S \u00d6vey","year":"2015","unstructured":"\u00d6vey \u0130S, Naziro\u011flu M (2015) Homocysteine and cytosolic GSH depletion induce apoptosis and oxidative toxicity through cytosolic calcium overload in the hippocampus of aged mice: involvement of TRPM2 and TRPV1 channels. Neuroscience 284:225\u2013233","journal-title":"Neuroscience"},{"issue":"4","key":"11038_CR34","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3390\/biom10040653","volume":"10","author":"T Panagaki","year":"2020","unstructured":"Panagaki T, Randi EB, Szabo C (2020) Role of 3-mercaptopyruvate sulfurtransferase in the regulation of proliferation and cellular bioenergetics in human Down syndrome fibroblasts. Biomolecules 10(4):653","journal-title":"Biomolecules"},{"key":"11038_CR35","doi-asserted-by":"publisher","first-page":"102416","DOI":"10.1016\/j.redox.2022.102416","volume":"55","author":"T Panagaki","year":"2022","unstructured":"Panagaki T, Pecze L, Randi EB, Nieminen AI, Szabo C (2022) Role of the cystathionine \u03b2-synthase \/ H(2)S pathway in the development of cellular metabolic dysfunction and pseudohypoxia in down syndrome. Redox Biol 55:102416","journal-title":"Redox Biol"},{"issue":"6","key":"11038_CR36","doi-asserted-by":"publisher","first-page":"e16910","DOI":"10.1016\/j.heliyon.2023.e16910","volume":"9","author":"MA Rather","year":"2023","unstructured":"Rather MA, Khan A, Wang L, Jahan S, Rehman MU, Makeen HA et al (2023) TRP channels: role in neurodegenerative diseases and therapeutic targets. Heliyon 9(6):e16910","journal-title":"Heliyon"},{"issue":"9","key":"11038_CR37","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1177\/0271678X16655551","volume":"36","author":"RG Rempe","year":"2016","unstructured":"Rempe RG, Hartz AMS, Bauer B (2016) Matrix metalloproteinases in the brain and blood-brain barrier: versatile breakers and makers. J Cereb Blood Flow Metab 36(9):1481\u20131507","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"11038_CR38","doi-asserted-by":"publisher","first-page":"18129","DOI":"10.1038\/s41598-023-44807-y","volume":"13","author":"WK Rumbeiha","year":"2023","unstructured":"Rumbeiha WK, Kim DS, Min A, Nair M, Giulivi C (2023) Disrupted brain mitochondrial morphology after in vivo hydrogen sulfide exposure. Sci Rep 13(1):18129","journal-title":"Sci Rep"},{"key":"11038_CR39","doi-asserted-by":"publisher","first-page":"1191714","DOI":"10.3389\/fnagi.2023.1191714","volume":"15","author":"L Sacchi","year":"2023","unstructured":"Sacchi L, Arcaro M, Carandini T, Pietroboni AM, Fumagalli GG, Fenoglio C et al (2023) Association between enlarged perivascular spaces and cerebrospinal fluid aquaporin-4 and tau levels: report from a memory clinic. Front Aging Neurosci 15:1191714","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"11038_CR40","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3390\/medicina59050917","volume":"59","author":"T Shulyatnikova","year":"2023","unstructured":"Shulyatnikova T, Hayden MR (2023) Why are perivascular spaces important? Medicina (Kaunas) 59(5):917","journal-title":"Medicina (Kaunas)"},{"key":"11038_CR41","doi-asserted-by":"publisher","DOI":"10.1101\/2023.06.02.543504","author":"F Sibilia","year":"2023","unstructured":"Sibilia F, Sheikh-Bahaei N, Mack WJ, Choupan J (2023) Perivascular spaces in Alzheimer\u2019s disease are associated with inflammatory, stress-related, and hypertension biomarkers. bioRxiv. https:\/\/doi.org\/10.1101\/2023.06.02.543504","journal-title":"bioRxiv"},{"issue":"1","key":"11038_CR42","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1139\/cjpp-2020-0224","volume":"99","author":"D Stanisic","year":"2021","unstructured":"Stanisic D, George AK, Smolenkova I, Singh M, Tyagi SC (2021) Hyperhomocysteinemia: an instigating factor for periodontal disease. Can J Physiol Pharmacol 99(1):115\u2013123","journal-title":"Can J Physiol Pharmacol"},{"key":"11038_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2022.12.003","volume":"511","author":"KL Tan","year":"2023","unstructured":"Tan KL, Lee HC, Cheah PS, Ling KH (2023) Mitochondrial dysfunction in down syndrome: from pathology to therapy. Neuroscience 511:1\u201312","journal-title":"Neuroscience"},{"issue":"12","key":"11038_CR44","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/jir.12784","volume":"64","author":"S Thalman","year":"2020","unstructured":"Thalman S, Van Pelt KL, Lin AL, Johnson NF, Jicha G, Caban-Holt A et al (2020) A preliminary study of cerebral blood flow, aging and dementia in people with Down syndrome. J Intellect Disabil Res 64(12):934\u2013945","journal-title":"J Intellect Disabil Res"},{"issue":"1","key":"11038_CR45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/BF01772207","volume":"126","author":"SC Tyagi","year":"1993","unstructured":"Tyagi SC, Ratajska A, Weber KT (1993) Myocardial matrix metalloproteinase(s): localization and activation. Mol Cell Biochem 126(1):49\u201359","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"11038_CR46","first-page":"441","volume":"46","author":"N Tyagi","year":"2009","unstructured":"Tyagi N, Mishra PK, Tyagi SC (2009) Homocysteine, hydrogen sulfide (H2S) and NMDA-receptor in heart failure. Indian J Biochem Biophys 46(6):441\u2013446","journal-title":"Indian J Biochem Biophys"},{"issue":"2","key":"11038_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00335-004-2428-7","volume":"16","author":"AJ Villar","year":"2005","unstructured":"Villar AJ, Belichenko PV, Gillespie AM, Kozy HM, Mobley WC, Epstein CJ (2005) Identification and characterization of a new Down syndrome model, Ts[Rb(12.1716)]2Cje, resulting from a spontaneous Robertsonian fusion between T(171)65Dn and mouse chromosome 12. Mamm Genome 16(2):79\u201390","journal-title":"Mamm Genome"},{"key":"11038_CR48","doi-asserted-by":"publisher","first-page":"814285","DOI":"10.3389\/fphys.2022.814285","volume":"13","author":"S Wang","year":"2022","unstructured":"Wang S, Wang B, Shang D, Zhang K, Yan X, Zhang X (2022) Ion Channel dysfunction in astrocytes in neurodegenerative diseases. Front Physiol 13:814285","journal-title":"Front Physiol"},{"issue":"2","key":"11038_CR49","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1007\/s00330-023-10122-3","volume":"34","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wang Y, Jiao B, Wang Z, Shi J, Zhang Y et al (2024) Glymphatic system impairment in Alzheimer\u2019s disease: associations with perivascular space volume and cognitive function. Eur Radiol 34(2):1314\u20131323","journal-title":"Eur Radiol"},{"key":"11038_CR50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.niox.2022.07.007","volume":"128","author":"K Zuhra","year":"2022","unstructured":"Zuhra K, Petrosino M, Gupta B, Panagaki T, Cecconi M, Myrianthopoulos V et al (2022) Epigallocatechin gallate is a potent inhibitor of cystathionine beta-synthase: structure-activity relationship and mechanism of action. Nitric Oxide 128:12\u201324","journal-title":"Nitric Oxide"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-025-11038-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-025-11038-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-025-11038-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:02:17Z","timestamp":1773399737000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-025-11038-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["11038"],"URL":"https:\/\/doi.org\/10.1007\/s10528-025-11038-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4010126\/v1","asserted-by":"object"}]},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"4 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}